CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase 3 XRay Vision study design - supplementary material
Author
Andre Konig (17766383)
Christophe Le Tourneau (10646294)
+8Â more
Hisham Mehanna (298212)
Jonathan D. Schoenfeld (12100222)
Makoto Tahara (5686613)
Marcis Bajars (7546727)
Pauline Witzler (17766386)
Robert Haddad (3501962)
Robert L. Ferris (616113)
Sue S. Yom (9563173)
Publication venue
Publication date
10/01/2024
Field of study
No full text
Infographic</p
The Francis Crick Institute
No full text
